<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=AB-001</id>
	<title>AB-001 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=AB-001"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=AB-001&amp;action=history"/>
	<updated>2026-04-26T05:24:09Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=AB-001&amp;diff=5385017&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=AB-001&amp;diff=5385017&amp;oldid=prev"/>
		<updated>2024-03-10T22:17:37Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;AB-001&amp;#039;&amp;#039;&amp;#039; is a synthetic cannabinoid that was discovered by the team at the pharmaceutical company, Abbott Laboratories. It is a full agonist of the CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; receptor, which is found in the brain and central nervous system. This receptor is one of the two main types of cannabinoid receptors in the body, the other being the CB&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt; receptor.&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
AB-001 is a member of the [[amide]] class of cannabinoids, which are known for their potent activity at the CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; receptor. The chemical structure of AB-001 includes a naphthoyl group, which is a common feature of many synthetic cannabinoids. This group is attached to an aminoalkylindazole group, which is a unique feature of AB-001 and a few other synthetic cannabinoids.&lt;br /&gt;
&lt;br /&gt;
[[File:AB-001_structure.png|thumb|right|Chemical structure of AB-001]]&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
AB-001 acts as a full agonist at the CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; receptor, meaning it can fully activate this receptor. This is in contrast to partial agonists, which can only partially activate the receptor. The activity of AB-001 at the CB&amp;lt;sub&amp;gt;1&amp;lt;/sub&amp;gt; receptor is believed to be responsible for its psychoactive effects.&lt;br /&gt;
&lt;br /&gt;
==Effects==&lt;br /&gt;
The effects of AB-001 are similar to those of [[tetrahydrocannabinol]] (THC), the main psychoactive compound in cannabis. These effects can include relaxation, euphoria, and altered perception. However, as a synthetic cannabinoid, AB-001 can also have additional effects not seen with natural cannabinoids. These can include increased heart rate, anxiety, and in some cases, severe psychotic episodes.&lt;br /&gt;
&lt;br /&gt;
==Legal Status==&lt;br /&gt;
The legal status of AB-001 varies by country. In many places, it is classified as a controlled substance due to its psychoactive effects and potential for abuse. However, in some countries, it is legal to possess and use AB-001 for research purposes.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Synthetic cannabinoids]]&lt;br /&gt;
* [[Cannabinoid receptor]]&lt;br /&gt;
* [[Amide]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Synthetic cannabinoids]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Chemistry]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>